Evidence map›Paper›PMID 21273441›Full record

ArticleMolecular endocrinology (Baltimore, Md.)2011

Lysine methylation and functional modulation of androgen receptor by Set9 methyltransferase.

Soyoung Ko, Jungmi Ahn, Chung S Song, Soyoung Kim, Katarzyna Knapczyk-Stwora, Bandana Chatterjee

Abstract read
In one paragraph

Article in Molecular endocrinology (Baltimore, Md.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 92 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Lysine and arginine methylation of transcription factors.Cellular and molecular life sciences : CMLS · 2024
    Review
  7. Article
  8. Review
  9. Article
  10. SETD7 functions as a transcription repressor in prostate cancer via methylating FOXA1.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Epigenetic Coregulation of Androgen Receptor Signaling.Advances in experimental medicine and biology · 2022
    Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Soyoung KoDepartment of Molecular Medicine/Institute Biotechnology, The University of Texas Health Science Center at San Antonio, 15355 Lambda Drive, San Antonio, Texas 78245, USA.
Jungmi Ahn
Chung S Song
Soyoung Kim
Katarzyna Knapczyk-Stwora
Bandana Chatterjee
The University of Texas Health Science Center at San Antonio · US

Funding

AGING AND ANDROGEN RECEPTOR GENE REGULATIONR01AG010486 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CHATTERJEE, BANDANA · 1993 to 2007
$1.1M
Aging and Prostatic Hyperplasia in Transgenic MiceR01AG019660 · NIA · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI CHATTERJEE, BANDANA · 2002 to 2005
$1.0M
NIA NIH HHS R01 AG010486NIA NIH HHS R01 AG019660NIA NIH HHS R01-AG10486NIA NIH HHS R01-AG19660
6 · The paper itself

Abstract

Lysine methyltransferases modulate activities of transcription factors and transcription coregulators by methylating specific lysine residue(s). We report that the androgen receptor (AR) is methylated at lysine-630 by Set9, which was originally identified as a histone H3K4 monomethyltransferase. Alanine substitution of lysine-630 prevented AR methylation in vitro and in vivo. Set9 methylated the nuclear and cytoplasmic AR utilizing the cofactor S-adenosyl-methionine. A pan-methyllysine antibody recognized endogenous AR, and Set9 coimmunoprecipitated with nuclear and cytoplasmic AR. Set9 overexpression potentiated AR-mediated transactivation of the probasin promoter, whereas Set9 depletion inhibited AR activity and target gene expression. Similar to AR, chromatin occupancy of Set9 at androgen response elements (AREs) was androgen dependent, and associated with methylated histone H3K4 chromatin activation marks and p300/CBP associated factor acetyltransferase recruitment. Set9 depletion increased the histone H3K9-dimethyl repressive mark at AREs and reduced histone activation marks and occupancy of p300/CBP associated factor. K630A mutation reduced amino- and carboxy-terminal (N-C) interaction in Set9-intact cells, whereas N-C interaction for wild-type AR was reduced upon Set9 depletion. The K630A mutant was resistant to loss of activity from Set9 silencing and to increase of activity from Set9 overexpression. The K630 dependence of Set9-regulated N-C interaction and AR activity suggests that Set9 directly acts on AR at the amino acid level. Chromatin recruitment of Set9 to AREs is suggestive of its additional role as a transcriptional coactivator. Because the cellular metabolic state determines the level of S-adenosylmethionine and consequently the activity of Set9, the enhanced activity of methylated AR may have special significance in certain metabolic contexts.

Indexed as

Blotting, WesternCell Line, TumorHistone-Lysine N-MethyltransferaseHumansImmunoprecipitationLysineMethylationMutationReceptors, AndrogenHistone-Lysine N-MethyltransferaseLysineReceptors, AndrogenSETD7 protein, human

Identifiers

PMID21273441
PMCPMC3045741
OpenAlexW2115630484

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.